Soleno Therapeutics (SLNO) Other Working Capital Changes (2013 - 2026)
Soleno Therapeutics' (SLNO) quarterly Other Working Capital Changes came in at -$133000.0 in Q1 2026, down 232.5% year-on-year from $100377.4 in Q1 2025, and down 232.5% on a QoQ basis from -$40000.0 in Q1 2025.
Soleno Therapeutics (SLNO) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has 6 years of Other Working Capital Changes data on file, last reported at -$133000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 232.5% year-over-year to -$133000.0 in Q1 2026; TTM through Mar 2026 was -$354000.0, a 59.46% decrease from a year earlier, with the FY2025 full-year figure at -$308000.0, down 68.31% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$133000.0, down from -$40000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for SLNO reached as high as $4.9 million in Q4 2025 and fell as low as -$3.5 million in Q2 2025.
- Historically, Other Working Capital Changes has averaged $319529.4 across 5 years, with a median of -$26000.0 in 2024.
- Across the five-year window, Other Working Capital Changes soared 93.75% in 2024 and tumbled 3900.0% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at -$308000.0 in 2023, then surged by 41.56% to -$180000.0 in 2024, then soared by 77.78% to -$40000.0 in 2025, then tumbled by 232.5% to -$133000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$133000.0 in Q1 2026, -$40000.0 in Q1 2025, and -$180000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -780,000.00 |
| Mar 31, 2026 | -780,000.00 |
| Mar 31, 2026 | -780,000.00 |
| Dec 31, 2025 | 4.93 Mn |
| Dec 31, 2025 | 4.93 Mn |
| Dec 31, 2025 | 4.93 Mn |
| Sep 30, 2025 | -115,000.00 |
| Sep 30, 2025 | -115,000.00 |
| Sep 30, 2025 | -115,000.00 |
| Jun 30, 2025 | -3.49 Mn |
| Jun 30, 2025 | -3.49 Mn |
| Jun 30, 2025 | -3.49 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | -172,000.00 |
| Sep 30, 2024 | -172,000.00 |